Azra Raza In Conversation With Siddhartha Mukherjee

NEW YORK, October 21, 2019 - Why has so little progress been made in preventing, diagnosing, and treating cancer? How can physicians, caregivers, and patients advocate for more effective research and humane treatments? Dr. Azra Raza, the director of the MDS Center at Columbia University, tackles some of these important questions in The First Cell: And the Human Costs of Pursuing Cancer to the Last. She appeared in conversation with Siddhartha Mukherjee, the Pulitzer Prize-winning author of The Empire of All Maladies and The Cell. (1 hr., 4 min.)

[@SonaliSenguptasengupso41]

Bless you Dr. Azra. Do not yield. Love always.

[@theHerathrig]

Very fascinating! This is important. Please share it with others or your doctor.

[@bennguyen1313]

If the single biggest risk factor (by far) of getting cancer is aging.. then treating it as a disease, like that of infection, seems doomed from the start.
Regarding the 27m mark, I thought PSA screenings suffer from false-positive.. but not that it actually increases cancer (like the ultrasound thyroid example in S.Korea). Also, any thoughts on the 4Kscore?
Would have like to have heard more about machine learning and perhaps the work by Mary Lou Jepsen, who is researching a very innovative and inexpensive approach to screening! Dannielle Engle interview on the Salk's Where Cures Begin podcast, mentions the particular difficulty with detecting pancreatic cancer.
BTW, there was a great article by Siddhartha in the New Yorker called 'The Promise and Price of Cellular Therapies'.